Trial intelligence / Profile preview

Ziprasidone in Bipolar I Depression

NCT00282464Phase 3Completed

Sponsor
Viatris
Start
Feb 2006
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started Feb 2006; status: completed.

02

Drugs

ziprasidone
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00282464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00282464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call